Kidney disease drug developer Maze files for $100M IPO (IPO:NYSEARCA)

Chronic kidney disease developer Maze Therapeutics ( MAZE ) has filed to raise $100 million through an initial public offering.

While the company did not disclose the terms in its SEC filingstated in the filing fee schedule that it did